Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.
about
Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptorsLiver regeneration is promoted by increasing serotonin content in rat liver with secondary biliary cirrhosis.New classes of antihypertensive drugs: therapeutic potentials.Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertensionBlockade of 5-HT2 receptor selectively prevents MDMA-induced verbal memory impairmentCarvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.A Serotonin Circuit Acts as an Environmental Sensor to Mediate Midline Axon Crossing through EphrinB2.Effects of MDMA on body temperature in humansPharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.Synthesis of new quinazolin-2,4-diones as anti-Leishmania mexicana agents.Antihypertensive therapy in the geriatric patient: II. A review of the alpha1-adrenergic blocking agents.MDMA-Induced Dissociative State not Mediated by the 5-HT2A Receptor.5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials.Effects of ketanserin and haloperidol on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man.Blockade of 5-HT(2A) receptors by sarpogrelate protects the heart against myocardial infarction in rats.Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication.MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor.Age-dependent effect of ketanserin on the sleep-waking phases in rats.Synthesis, Structure of Zwitterionic 2-Amino-N′-(imidazolidin-2-ylidene)benzohydrazides, and Their Transformation into 3-(Imidazolidin-2-ylideneamino)quinazolin-4(1H)-one Derivatives
P2860
Q28727300-A6A171D4-4D96-40D8-A653-20CCE520A50FQ33395901-BCF1651E-B555-49D7-B96B-DB4BA1DCAF61Q33537656-5F75E51B-7914-4D59-BF49-167E7C284FE1Q33634204-373B5C46-6B37-42D1-9414-829B9D145C0FQ35158204-ADF39EA5-989A-48BC-9409-59698CAECED7Q36252777-F18A3DD8-F5DC-4AE9-89ED-C266A0F34370Q36254063-3F8BDE0D-9543-4D91-86DB-4533B0D0ED3BQ37226598-169BCD22-5684-4D07-AF9A-62E579D5EE6BQ38048826-D1CB46F1-B4AB-4DFF-A7DB-405CDF81131DQ38751498-1C87B7B3-0D88-46FF-998B-A6E572216A39Q40708111-23FA9E1C-FD65-43DF-BFDB-6ABFFA70E8A2Q40977003-389BB1F7-0DF0-48EA-9E99-0CDAEB079C51Q41980535-F7734E65-9367-4081-98C9-EDCB10C1AEB2Q43956668-70465D53-5789-4B15-B532-16BA67BA996AQ43986745-12EC4235-ABAE-47CF-A555-0F0E4DE20CD4Q47587443-37C8C773-93E1-4874-BE7D-2F369FC8BBC1Q47770844-F9A45EDD-D6EB-4FBE-818C-B4352DF03D1AQ48794908-DD0F7083-C55D-4E82-9429-6B92CF212C6FQ58834273-9733F995-94E1-4791-915A-A99D35C3A424
P2860
Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.
description
1990 nî lūn-bûn
@nan
1990 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Ketanserin. A review of its ph ...... d peripheral vascular disease.
@ast
Ketanserin. A review of its ph ...... d peripheral vascular disease.
@en
type
label
Ketanserin. A review of its ph ...... d peripheral vascular disease.
@ast
Ketanserin. A review of its ph ...... d peripheral vascular disease.
@en
prefLabel
Ketanserin. A review of its ph ...... d peripheral vascular disease.
@ast
Ketanserin. A review of its ph ...... d peripheral vascular disease.
@en
P1433
P1476
Ketanserin. A review of its ph ...... d peripheral vascular disease.
@en
P2093
P304
P356
10.2165/00003495-199040060-00010
P577
1990-12-01T00:00:00Z
P6179
1030978181